Johnson & Johnson
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.About JNJ
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech.
CEOJoaquin Duato
CEOJoaquin Duato
Employees152,700
Employees152,700
HeadquartersNew Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded1887
Founded1887
Employees152,700
Employees152,700
JNJ Key Statistics
Market cap389.30B
Market cap389.30B
Price-Earnings ratio33.00
Price-Earnings ratio33.00
Dividend yield2.81%
Dividend yield2.81%
Average volume6.76M
Average volume6.76M
High today$163.49
High today$163.49
Low today$161.59
Low today$161.59
Open price$162.61
Open price$162.61
Volume4.52M
Volume4.52M
52 Week high$181.04
52 Week high$181.04
52 Week low$150.11
52 Week low$150.11
JNJ News
Benzinga 12h
Zika Virus Market to Witness Growth by 2032, Estimates DelveInsight | Johnson and Johnson, Aurobindo Phar - Benzinga"Zika Virus Market" (Albany, USA) DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understandi...
Benzinga 22h
Cutaneous Mastocytosis Treatment Market | Bausch Health Companies Inc., Bayer AG, Johnson & Johnson, Mall - BenzingaThe global cutaneous mastocytosis treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of...
Yahoo Finance 3d
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results - Yahoo FinanceNEW BRUNSWICK, N.J., September 18, 2023--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on...
Analyst ratings
63%
of 24 ratingsBuy
33.3%
Hold
62.5%
Sell
4.2%
JNJ Earnings
$0.00
$0.93
$1.87
$2.80
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Q3 FY23
Estimated$2.51 per share
Estimated$2.51 per share
ActualAvailable Oct 17, Pre-Market
ActualAvailable Oct 17, Pre-Market
More JNJ News
Fortune 7d
This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech businessGood morning, Broadsheet readers! Former Alibaba Group adviser Wei Zhang will join the Starbucks board, Iranian women are still fighting for their rights, and a...